Diving into the Future: Hurdle Secures $8M in Series A Funding to Revolutionize Bio-Infrastructure

We are thrilled to announce that Hurdle has successfully raised $8 million in our latest funding round, a significant step towards our mission of democratizing access to biology for both companies and consumers. As a pioneering force in cutting-edge bio-infrastructure, Hurdle combines deep expertise with a tech-driven platform that seamlessly integrates with any business system. This new funding will allow us to enhance our modular and end-to-end capabilities, ensuring that biology data is not only accessible but also actionable for organizations seeking to break traditional barriers. Our commitment is to empower businesses with tailored solutions that can help boost revenue, widen consumer reach, and unlock new opportunities. The support from our investors is a powerful endorsement of our vision, as we strive to transform the way businesses harness the profound power of biology. With this investment, we are poised to accelerate the development of tools and resources that will catalyze change, ultimately leading to a more informed and healthier future. At Hurdle, we are not just a platform; we are a movement dedicated to unlocking biology’s untapped potential and providing the deep insights organizations need to thrive. Join us on this exciting journey as we continue to pave the way for innovation in the biological landscape. Learn more about the Hurdle difference at hurdle.bio. Proudly backed by Chronomics Ltd. Inc., we are excited about the future and the impact we can create together.